151 related articles for article (PubMed ID: 11481521)
1. Cytomorphometric parameters and the metastatic potential of cutaneous and uveal melanoma: a comparison with prognostic factors.
Burnier Pereira F; Burnier MN; Shibata H; Wang B; Carey W
Am J Dermatopathol; 2001 Aug; 23(4):304-7. PubMed ID: 11481521
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of morphometric features and the callender classification in uveal melanomas.
Coleman K; Baak JP; van Diest PJ; Mullaney J
Ophthalmology; 1996 Oct; 103(10):1634-41. PubMed ID: 8874437
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous dysplastic naevi in uveal melanoma patients: markers for prognosis?
Tóth-Molnár E; Hammer H; Oláh J
Melanoma Res; 2000 Feb; 10(1):36-9. PubMed ID: 10711638
[TBL] [Abstract][Full Text] [Related]
4. A simple cytologic method for predicting the malignant potential of intraocular melanoma.
Huntington A; Haugan P; Gamel J; McLean I
Pathol Res Pract; 1989 Nov; 185(5):631-4. PubMed ID: 2696944
[TBL] [Abstract][Full Text] [Related]
5. Uveal melanoma: mean of the longest nucleoli measured on silver-stained sections.
Moshari A; McLean IW
Invest Ophthalmol Vis Sci; 2001 May; 42(6):1160-3. PubMed ID: 11328722
[TBL] [Abstract][Full Text] [Related]
6. ADAM 10 expression in primary uveal melanoma as prognostic factor for risk of metastasis.
Caltabiano R; Puzzo L; Barresi V; Ieni A; Loreto C; Musumeci G; Castrogiovanni P; Ragusa M; Foti P; Russo A; Longo A; Reibaldi M
Pathol Res Pract; 2016 Nov; 212(11):980-987. PubMed ID: 27546281
[TBL] [Abstract][Full Text] [Related]
7. A comparison of prognostic covariates for uveal melanoma.
Gamel JW; McCurdy JB; McLean IW
Invest Ophthalmol Vis Sci; 1992 May; 33(6):1919-22. PubMed ID: 1582798
[TBL] [Abstract][Full Text] [Related]
8. Increased chondroitin sulphate proteoglycan expression (B5 immunoreactivity) in metastases of uveal melanoma.
Kiewe P; Bechrakis NE; Schmittel A; Ruf P; Lindhofer H; Thiel E; Nagorsen D
Ann Oncol; 2006 Dec; 17(12):1830-4. PubMed ID: 16971663
[TBL] [Abstract][Full Text] [Related]
9. Prognostic implications of cytopathologic classification of melanocytic uveal tumors evaluated by fine-needle aspiration biopsy.
Augsburger JJ; Corrêa ZM; Trichopoulos N
Arq Bras Oftalmol; 2013; 76(2):72-9. PubMed ID: 23828465
[TBL] [Abstract][Full Text] [Related]
10. Expression and prognostic significance of iNOS in uveal melanoma.
Johansson CC; Mougiakakos D; Trocme E; All-Ericsson C; Economou MA; Larsson O; Seregard S; Kiessling R
Int J Cancer; 2010 Jun; 126(11):2682-9. PubMed ID: 19847812
[TBL] [Abstract][Full Text] [Related]
11. A simple, efficient, and reproducible method for estimating the malignant potential of uveal melanoma from routine H & E slides.
McCurdy J; Gamel J; McLean I
Pathol Res Pract; 1991 Dec; 187(8):1025-7. PubMed ID: 1792184
[TBL] [Abstract][Full Text] [Related]
12. Treatment of uveal melanoma metastatic to the liver: a review of the M. D. Anderson Cancer Center experience and prognostic factors.
Bedikian AY; Legha SS; Mavligit G; Carrasco CH; Khorana S; Plager C; Papadopoulos N; Benjamin RS
Cancer; 1995 Nov; 76(9):1665-70. PubMed ID: 8635073
[TBL] [Abstract][Full Text] [Related]
13. The value of nucleolar organizer regions in uveal melanoma. The Collaborative Ocular Melanoma Study Group.
Marcus DM; Minkovitz JB; Wardwell SD; Albert DM
Am J Ophthalmol; 1990 Nov; 110(5):527-34. PubMed ID: 1700611
[TBL] [Abstract][Full Text] [Related]
14. Prognostic accuracy of the mean of the largest nucleoli, vascular patterns, and PC-10 in posterior uveal melanoma.
Seregard S; Spångberg B; Juul C; Oskarsson M
Ophthalmology; 1998 Mar; 105(3):485-91. PubMed ID: 9499780
[TBL] [Abstract][Full Text] [Related]
15. Angiotropism and extravascular migratory metastasis in cutaneous and uveal melanoma progression in a zebrafish model.
Fornabaio G; Barnhill RL; Lugassy C; Bentolila LA; Cassoux N; Roman-Roman S; Alsafadi S; Del Bene F
Sci Rep; 2018 Jul; 8(1):10448. PubMed ID: 29992995
[TBL] [Abstract][Full Text] [Related]
16. PC-10 as a predictor of prognosis after antigen retrieval in posterior uveal melanoma.
Seregard S; Oskarsson M; Spångberg B
Invest Ophthalmol Vis Sci; 1996 Jun; 37(7):1451-8. PubMed ID: 8641848
[TBL] [Abstract][Full Text] [Related]
17. Variations in the ganglioside profile of uveal melanoma correlate with cytologic heterogeneity.
Kanda S; Cochran AJ; Lee WR; Morton DL; Irie RF
Int J Cancer; 1992 Nov; 52(5):682-7. PubMed ID: 1428227
[TBL] [Abstract][Full Text] [Related]
18. [THE BRAF MUTATION AND THE POSSIBILITIES OF UVEAL MELANOMA METASTASING PROGNOSTIC MARKERS IDENTIFICATION].
Horkovičová K; Markus J; Krčová I; Babál P; Kobzová D; Smolková B
Cesk Slov Oftalmol; 2016; 72(4):149-156. PubMed ID: 27860480
[TBL] [Abstract][Full Text] [Related]
19. Prognostic parameters in uveal melanoma: a review.
Mooy CM; De Jong PT
Surv Ophthalmol; 1996; 41(3):215-28. PubMed ID: 8970236
[TBL] [Abstract][Full Text] [Related]
20. HNK-1 antigens on uveal and cutaneous melanoma cell lines.
Tang NE; Luyten GP; Mooy CM; Naus NC; de Jong PT; Luider TM
Melanoma Res; 1996 Dec; 6(6):411-8. PubMed ID: 9013478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
